You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Responsible Drinking: Internet-based, Interactive Computer Tailored Intervention
SBC: Pro-Change Behavior Systems, Inc. Topic: NIAAADESCRIPTION (provided by applicant): Excessive alcohol use is associated with a range of serious and costly health, social, and economic consequences at the individual and societal level. This program of research serves as a venue by which to produce and test an innovative, science-based, and cost-effective means to intervene in a private, convenient, and individualized way with employed adults wh ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Computerized Stage-Matched Intervention for Juvenile Offenders
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDADESCRIPTION (provided by applicant): Juvenile crime imposes enormous costs on victims, on society, and on juvenile offenders themselves. However, research assessing the efficacy of interventions for young offenders show, on average, only small effects on recidivism, substance abuse, and other behavioral outcomes. A major problem with existing interventions is that they tend to neglect individual d ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
EpiVax Phase II SBIR: Preclinical studies of Tregitope Delivery and Mechanism of
SBC: EPIVAX, INC. Topic: NIDDKDESCRIPTION (provided by applicant): The goal of this Phase II project is to advance the development of novel tolerance-inducing peptides (Tregitopes) to prevent and/or treat Type 1 diabetes (T1D) by optimizing the clinical delivery vehicle and treatment protocol, and by identifying correlates of efficacy in preparation for Phase 1 clinical trials. More than 13,000 children in the U.S. are diagnos ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Novel antithrombotic agents to prevent hemodialysis vascular access failure
SBC: EVAS THERAPEUTICS LLC Topic: NHLBIDESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthetic graft (AVG). Unfortunately, primary failure rates were as high as 60 % at 6 months after AVF creation and 77% at 1 year after AVG construction. Surgical trauma, repeated needle punctures, mechani ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Adjunctive Use of Apyrase to Fibrinolytic Therapy
SBC: APT THERAPEUTICS, INC. Topic: NHLBIDESCRIPTION (provided by applicant): Acute myocardial infarction is the leading cause of death in most industrialized nations. The estimated annual incidence in the US is 865,000 events, with ST-segment elevation myocardial infarction (STEMI, severe AMI)comprising an estimated 500,000 events per year. Fibrinolytic therapy is widely utilized to restore coronary blood flow due to its widespread ava ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Improved long-term biocompatibility of coronary stents by plasma coating process
SBC: NANOVA INC. Topic: NHLBIDESCRIPTION (provided by applicant): Improved long-term biocompatibility of coronary stents by plasma coating process Abstract Drug-eluting stents (DES) have been widely used to treat patients of cardiac disease due to their better ability to control restenosis than bare metal stents (BMS). However, a serious adverse outcome of late stent thrombosis in patients treated with DES has been reported, ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Treatment of Transplant Reperfusion with CD47 antibody
SBC: VASCULOX, INC. Topic: NHLBIDESCRIPTION (provided by applicant): Vasculox, Inc. is developing a humanized anti-CD47 mAb for reducing ischemia-reperfusion injury (IRI) in organ transplantation. In spite of improvements in surgical technique, organ preservation and immunosuppression, IRI remains a serious limitation and is responsible for delayed graft function, initial graft failure and contribtes to poor long-term graft surv ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Improved TTHM Reduction Processing and Operational Efficiencies in Potable Water Distributions Systems Using Solar-Powered Circulation with Diffused, Near-Surface Aeration
SBC: SolarBee, Inc. Topic: AThe U.S. EPA Stage 2 Disinfectants and Disinfection Byproducts Rule (S2DDBR) requires potable water utilities to maintain total trihalomethane (TTHM) concentrations below 80µg/L at all locations within distribution systems beginning in 2012 due to adverse health-effect risks. Air stripping effectively volatilizes TTHMs due to their low Henry’s law constants. However, commercially available ai ...
SBIR Phase I 2012 Environmental Protection Agency -
Development of Robust Distributed Ceramic Coaxial Cable Sensors for High Temperature Harsh Environment Applications
SBC: Habsonic LLC Topic: 14bThe interconnected consequences of the national energy strategy compel us to design energy systems to operate at higher temperatures to achieve greater efficiency and reduced greenhouse gas emissions. The success of various promising clean coal technologies will rely in part on sensors that can perform reliably in the harsh environments involved in these energy systems for process optimization and ...
SBIR Phase I 2012 Department of Energy -
Solid Polymer Electrolytes with High Lithium Ion Conductivity and Transport Number for Hybrid Electric Power-train Systems
SBC: HYBRID PLASTICS Topic: 09bCurrent energy storage devices have energy densities that are barely sufficient for low cost electric-vehicles and rely on lithium ion batteries that use flammable, unsafe, liquid electrolytes. However, in order to replace liquid electrolyes in lithium batteries for hybrid electric power train systems, solid polymer electrolytes, which have the advantages of safety and flexibility, must attain con ...
SBIR Phase I 2012 Department of Energy